Clinical Trial Update: Isatuximab in Type I Cryoglobulinemia [Phase 2]

View source ↗

Summary

Phase 2 trial update for isatuximab in cryoglobulinemic vasculitis associated with monoclonal gammopathies isatuximab is being studied; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryoglobulinemic Vasculitis
• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma

Drugs mentioned

• Isatuximab (isatuximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance | Phase 2 | Status: UNKNOWN